- Home
- KYMR vs RRR Comparison
KYMR vs RRR Comparison
Compare KYMR & RRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- RRR
- Stock Information
- Founded
- KYMR 2015
- RRR 1976
- Country
- KYMR United States
- RRR United States
- Employees
- KYMR N/A
- RRR N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- RRR Hotels/Resorts
- Sector
- KYMR Health Care
- RRR Consumer Discretionary
- Exchange
- KYMR Nasdaq
- RRR Nasdaq
- Market Cap
- KYMR 3.1B
- RRR 2.6B
- IPO Year
- KYMR 2020
- RRR 2016
- Fundamental
- Price
- KYMR $44.64
- RRR $56.13
- Analyst Decision
- KYMR Strong Buy
- RRR Buy
- Analyst Count
- KYMR 16
- RRR 13
- Target Price
- KYMR $58.94
- RRR $55.38
- AVG Volume (30 Days)
- KYMR 865.2K
- RRR 765.5K
- Earning Date
- KYMR 08-06-2025
- RRR 07-29-2025
- Dividend Yield
- KYMR N/A
- RRR 3.49%
- EPS Growth
- KYMR N/A
- RRR N/A
- EPS
- KYMR N/A
- RRR 2.60
- Revenue
- KYMR $58,885,000.00
- RRR $1,947,975,000.00
- Revenue This Year
- KYMR $58.26
- RRR $1.19
- Revenue Next Year
- KYMR N/A
- RRR $2.85
- P/E Ratio
- KYMR N/A
- RRR $21.62
- Revenue Growth
- KYMR N/A
- RRR 9.48
- 52 Week Low
- KYMR $19.45
- RRR $35.09
- 52 Week High
- KYMR $53.27
- RRR $61.73
- Technical
- Relative Strength Index (RSI)
- KYMR 55.84
- RRR 70.65
- Support Level
- KYMR $43.56
- RRR $54.47
- Resistance Level
- KYMR $46.34
- RRR $57.41
- Average True Range (ATR)
- KYMR 1.81
- RRR 1.31
- MACD
- KYMR -0.60
- RRR 0.29
- Stochastic Oscillator
- KYMR 36.21
- RRR 83.87
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About RRR Red Rock Resorts Inc.
Red Rock Resorts Inc along with its subsidiary is a gaming, development and management company that develops and operates strategically-located casino and entertainment properties. Its casino properties are conveniently located throughout the Las Vegas valley and provide its customers a wide variety of entertainment and dining options. The majority of revenue is derived from Casinos.